These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34182999)

  • 21. Mutation survey and genotype-phenotype analysis of COL2A1 and COL11A1 genes in 16 Chinese patients with Stickler syndrome.
    Wang X; Jia X; Xiao X; Li S; Li J; Li Y; Wei Y; Liang X; Guo X
    Mol Vis; 2016; 22():697-704. PubMed ID: 27390512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Heterozygous Mutation in the Triple Helical Region of the Alpha 1 (II) Chain of the COL2A1 Protein Causes Non-Lethal Spondyloepiphyseal Dysplasia Congenita.
    Almatrafi A; Alfadhli F; Khan YN; Afzal S; Hashmi JA; Ullah A; Albalawi AM; Basit S
    Genet Test Mol Biomarkers; 2019 May; 23(5):310-315. PubMed ID: 30932712
    [No Abstract]   [Full Text] [Related]  

  • 23. Case report of the first molecular diagnosis of Stickler syndrome with a pathogenic COL2A1 variant in a Mongolia family.
    Wu H; Che S; Li S; Cheng Y; Xiao J; Liu Z
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1781. PubMed ID: 34405586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel deep intronic COL2A1 mutation in a family with early-onset high myopia/ocular-only Stickler syndrome.
    Sun W; Xiao X; Li S; Jia X; Zhang Q
    Ophthalmic Physiol Opt; 2020 May; 40(3):281-288. PubMed ID: 32196734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IPSC reprogramming of two patients with spondyloepiphyseal dysplasia congenita (SEDC).
    De Kinderen P; Rabaut L; Perik MHAM; Peeters S; Ponsaerts P; Loeys B; Mortier G; Meester JAN; Verstraeten A
    Stem Cell Res; 2023 Jun; 69():103080. PubMed ID: 36966641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-exome sequencing reveals a novel COL2A1 mutation in a patient with spondylo-epiphyseal dysplasia congenita.
    Sangsin A; Srichomthong C; Pongpanich M; Suphapeetiporn K; Shotelersuk V
    Genet Mol Res; 2016 Mar; 15(1):15017624. PubMed ID: 26985960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Managment of cervical spine abnormalities in children with spondyloepiphyseal dysplasia congenita: Observational study.
    Al Kaissi A; Ryabykh S; Pavlova OM; Ochirova P; Kenis V; Chehida FB; Ganger R; Grill F; Kircher SG
    Medicine (Baltimore); 2019 Jan; 98(1):e13780. PubMed ID: 30608389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita.
    Unger S; Korkko J; Krakow D; Lachman RS; Rimoin DL; Cohn DH
    Am J Med Genet; 2001 Nov; 104(2):140-6. PubMed ID: 11746045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A first familial G504S mutation of COL2A1 gene results in distinctive spondyloepiphyseal dysplasia congenita.
    Xia X; Cui Y; Huang Y; Pan L; Wu Y; Zhang P; Jin B
    Clin Chim Acta; 2007 Jul; 382(1-2):148-50. PubMed ID: 17509551
    [No Abstract]   [Full Text] [Related]  

  • 30. The expanding spectrum of COL2A1 gene variants IN 136 patients with a skeletal dysplasia phenotype.
    Barat-Houari M; Dumont B; Fabre A; Them FT; Alembik Y; Alessandri JL; Amiel J; Audebert S; Baumann-Morel C; Blanchet P; Bieth E; Brechard M; Busa T; Calvas P; Capri Y; Cartault F; Chassaing N; Ciorca V; Coubes C; David A; Delezoide AL; Dupin-Deguine D; El Chehadeh S; Faivre L; Giuliano F; Goldenberg A; Isidor B; Jacquemont ML; Julia S; Kaplan J; Lacombe D; Lebrun M; Marlin S; Martin-Coignard D; Martinovic J; Masurel A; Melki J; Mozelle-Nivoix M; Nguyen K; Odent S; Philip N; Pinson L; Plessis G; Quélin C; Shaeffer E; Sigaudy S; Thauvin C; Till M; Touraine R; Vigneron J; Baujat G; Cormier-Daire V; Le Merrer M; Geneviève D; Touitou I
    Eur J Hum Genet; 2016 Jul; 24(7):992-1000. PubMed ID: 26626311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of a p.Pro786Leu variant in COL2A1 with mild spondyloepiphyseal dysplasia congenita in a three-generation family.
    Mark PR; Torres-Martinez W; Lachman RS; Weaver DD
    Am J Med Genet A; 2011 Jan; 155A(1):174-9. PubMed ID: 21204228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel MYO6 mutation associated with autosomal dominant non-syndromic hearing loss in a Chinese family by whole-exome sequencing.
    Tian T; Lu Y; Yao J; Cao X; Wei Q; Li Q
    Genes Genet Syst; 2018 Dec; 93(5):171-179. PubMed ID: 30175721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type.
    Tiller GE; Polumbo PA; Weis MA; Bogaert R; Lachman RS; Cohn DH; Rimoin DL; Eyre DR
    Nat Genet; 1995 Sep; 11(1):87-9. PubMed ID: 7550321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to a Col2a1 mutation.
    Esapa CT; Hough TA; Testori S; Head RA; Crane EA; Chan CP; Evans H; Bassett JH; Tylzanowski P; McNally EG; Carr AJ; Boyde A; Howell PG; Clark A; Williams GR; Brown MA; Croucher PI; Nesbit MA; Brown SD; Cox RD; Cheeseman MT; Thakker RV
    J Bone Miner Res; 2012 Feb; 27(2):413-28. PubMed ID: 22028304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the phenotype spectrum associated with pathogenic variants in the COL2A1 and COL11A1 genes.
    Čopíková J; Paděrová J; Románková V; Havlovicová M; Balaščáková M; Zelinová M; Vejvalková Š; Simandlová M; Štěpánková J; Hořínová V; Kantorová E; Křečková G; Pospíšilová J; Boday A; Meszarosová AU; Turnovec M; Votýpka P; Lišková P; Kremlíková Pourová R
    Ann Hum Genet; 2020 Sep; 84(5):380-392. PubMed ID: 32427345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biallelic variants p.Arg1133Cys and p.Arg1379Cys in COL2A1: Further delineation of phenotypic spectrum of recessive Type 2 collagenopathies.
    Girisha KM; Bhavani GS; Shah H; Moirangthem A; Shukla A; Kim OH; Nishimura G; Mortier GR
    Am J Med Genet A; 2020 Feb; 182(2):338-347. PubMed ID: 31755234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A form of autosomal dominant spondyloepiphyseal dysplasia is caused by a glycine to alanine substitution in the COL2A1 gene.
    Sellick GS; Hoornaert KP; Mortier GR; King C; Dolling CL; Newbury-Ecob RA; Gargan M; Hall CM; Houlston RS; Smithson SF
    Clin Dysmorphol; 2006 Oct; 15(4):197-202. PubMed ID: 16957471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene.
    Hoornaert KP; Dewinter C; Vereecke I; Beemer FA; Courtens W; Fryer A; Fryssira H; Lees M; Müllner-Eidenböck A; Rimoin DL; Siderius L; Superti-Furga A; Temple K; Willems PJ; Zankl A; Zweier C; De Paepe A; Coucke P; Mortier GR
    J Med Genet; 2006 May; 43(5):406-13. PubMed ID: 16155195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic characterization of patients with early-onset high myopia due to mutations in
    Zhou L; Xiao X; Li S; Jia X; Wang P; Sun W; Zhang F; Li J; Li T; Zhang Q
    Mol Vis; 2018; 24():560-573. PubMed ID: 30181686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent c.G1636A (p.G546S) mutation of COL2A1 in a Chinese family with skeletal dysplasia and different metaphyseal changes: a case report.
    Chen J; Ma X; Zhou Y; Li G; Guo Q
    BMC Pediatr; 2017 Jul; 17(1):175. PubMed ID: 28738883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.